Biomarkers are transforming how scientists understand and address complex diseases, from neurological disorders to cancer and autoimmune conditions. By harnessing advanced proteomics technologies, researchers are uncovering novel biomarkers that drive drug development, enable earlier diagnoses, and facilitate personalized therapies.
Download this compendium to learn
- The role of bottom-up proteomics in advancing biomarker identification and validation
- Strategies for predictive and prognostic biomarker applications across multiple diseases
- How robust data management ensures efficient proteomics workflows and data integrity
